Effects of fish oil containing eicosapentaenoic acid and docosahexaenoic acid on dystrophic mdx mice

Clinical Nutrition

Volumn 32, Issue 4, 2013, Pages 636-642

  Fogagnolo Mauricio, Adriana ^a   Minatel, Elaine ^a   Santo Neto, Humberto ^a   Marques, Maria Julia ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

DHA; DMD; Dystrophin; EPA; Skeletal muscle; TNF alpha

Indexed keywords

4 HYDROXYNONENAL; CREATINE KINASE; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; MINERAL OIL; OMEGA 3 FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BICEPS BRACHII MUSCLE; CONTROLLED STUDY; DIAPHRAGM MUSCLE; DISEASE MODEL; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; GRIP STRENGTH; HISTOPATHOLOGY; MALE; MOUSE; MUSCLE NECROSIS; MUSCLE STRENGTH; NONHUMAN; STERNOCLEIDOMASTOID MUSCLE; WESTERN BLOTTING;

ANIMALS; CREATINE KINASE; DIAPHRAGM; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; DYSTROPHIN; EICOSAPENTAENOIC ACID; FEMALE; FISH OILS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE STRENGTH; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; MUSCULAR DYSTROPHY, DUCHENNE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84879464224     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2012.11.013     Document Type: Article

References (33)

1. Engel A.G., Yamamoto M., Fischbeck K.H. Distrophinopathies. Myology 1994, 1133-1187. McGraw-Hill, New York. A.G. Engel, G.C. Franzini-Armstron (Eds.).
2. Bogdanovich S., Perkins K.J., Krag T.O.B., Khurana T.S. Therapeutics for Duchenne muscular dystrophy: current approaches and future directions. JMol Med (Berl) 2004, 82:102-115.
3. ®) therapy protects dystrophic skeletal muscle from necrosis. FASEB J 2004, 18:676-682.
4. Whitehead N.P., Yeung E.W., Allen D.G. Muscle damage in mdx (dystrophic) mice: role of calcium and reactive oxygen species. Clin Exp Pharmacol Physiol 2006, 33:657-662.
5. Tonon E., Ferretti R., Shiratori J.H., Santo Neto H., Marques M.J., Minatel E. Ascorbic acid protects the diaphragm muscle against myonecrosis in mdx mice. Nutrition 2012, 28:686-690.
6. Spencer M.J., Tidball J.G. Do immune cells promote the pathology of dystrophin-deficient myopathies?. Neuromuscul Disord 2001, 11:556-564.
7. Gosselin L.E., Williams J.E., Deering M., Brazeau D., Koury S., Martinez D.A. Localization and early time course of TGF-Beta1 mRNA expression in dystrophic muscle. Muscle Nerve 2004, 30:645-653.
8. Bonifati M.D., Ruzza G., Bonometto P., Berardinelli A., Gorni K., Orcesi S., et al. Amulticenter, double-blind, randomized trial of deflazacort versus prednisone in Duchenne muscular dystrophy. Muscle Nerve 2000, 23:1344-1347.
9. Simopoulos A.P. Omega-3 fatty acids in inflammation and autoimmune diseases. JAm Coll Nutr 2002, 21:495-505.
10. Gheita T., Kamel S., Helmy N., El-Laithy N., Monir A. Omega-3 fatty acids in juvenile idiopathic arthritis: effect on cytokines (IL-1 and TNF-α), disease activity and response criteria. Clin Rheumatol 2012, 31:363-366.
11. Manson J.E., Bassuk S.S., Lee I.M., Cook N.R., Albert M.A., Gordon D., et al. The VITamin D and Omega-3 Trial (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trial 2012, 33:159-171.
12. Machado R.V., Mauricio A.F., Taniguti A.P.T., Ferretti R., Santo Neto H., Marques M.J. Eicosapentaenoic acid decreases TNF-alpha and protects dystrophic muscles of mdx mice from degeneration. JNeuroimmunol 2011, 232:145-150.
13. Matsumoto T., Nakayama N., Ishida K., Kobayashi T., Kamata K. Eicosapentaenoic acid improves imbalance between vasodilator and vasoconstrictor actions of endothelium-derived factors in mesenteric arteries from rats at chronic stage of type 2 diabetes. JPharmacol Exp Ther 2009, 329:324-334.
14. Taniguti A.P., Pertille A., Matsumura C.Y., Santo Neto H., Marques M.J. Prevention of muscle fibrosis and myonecrosis in mdx mice by suramin, a TGF-beta 1 blocker. Muscle Nerve 2011, 43:82-87.
15. Messina S., Bitto A., Aguennouz M., Mazzeo A., Migliorato A., Poliyo F., et al. Flavocoxidcounteracts muscle necrosis and improves functional properties in mdx mice: a comparison study with methylprednisone. Exp Neurol 2009, 220:349-358.
16. Stedman H.H., Sweeney H.L., Shrager J.B., Maguire H.C., Panettieri R.A., Petrof B., et al. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 1991, 352:536-539.
17. Uchida K. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res 2003, 42:318-343.
18. Pinto R.S.M., Ferretti R., Moraes L.H.R., Santo Neto H., Marques M.J., Minatel E. N-acetylcysteine treatment reduces TNF-alpha levels and myonecrosis in diaphragm muscle of mdx mice. Clin Nutr 2012, published online Jun 23. 10.1016/j.clnu.2012.06.001.
19. Messina S., Altavilla D., Aquennouz M., Seminara P., Minutoli L., Monici M.C., et al. Lipid peroxidation inhibition blunts nuclear factor-kappaB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice. Am J Pathol 2006, 168:918-926.
20. Tuazon M.A., Henderson G.C. Fatty acid profile of skeletal muscle phospholipid is altered in mdx mice and predictive of disease markers. Metabolism 2012, 61:801-811.
21. Arterburn L.M., Hall E.B., Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 2006, 83:1467S-1476S.
22. Allen D.G., Whitehead N.P., Yeung E.W. Mechanisms of stretch-induced muscle damage in normal and dystrophic muscle: role of ionic changes. JPhysiol 2005, 567:723-735.
23. Kajikawa S., Imada K., Takeuchi T., Shimizu Y., Kawashima A., Harada T., et al. Eicosapentaenoic acid attenuates progression of hepatic fibrosis with inhibition of reactive oxygen species production in rats fed methionine- and choline-deficient diet. Dig Dis Sci 2010, 56:1065-1074.
24. Pound E.M., Kang J.X., Leaf A. Partitioning of polyunsaturated fatty acids, which prevent cardiac arrhythmias, into phospholipid cell membranes. JLipid Res 2001, 42:346-351.
25. Judè S., Roger S., Martel E., Besson P., Richard S., Bougnoux P., et al. Dietary long-chain omega-3 fatty acids of marine origin: a comparison of their protective effects on coronary heart disease and breast cancers. Prog Biophys Mol Biol 2006, 90:299-325.
26. Ye S., Tan L., Ma J., Shi Q., Li J. Polyunsaturated docosahexaenoic acid suppresses oxidative stress induce endothelial cell calcium influx by altering lipid composition in membrane caveolar rafts. Prostaglandins Leukot Essent Fatty Acids 2010, 83:37-43.
27. Tidball J.G. Inflammatory process in muscle injury and repair. Am J Physiol Regul Comp Physiol 2006, 288:R345-R353.
28. Chang H.R., Arsenijevic D., Pechère J.C., Piguet P.F., Mensi N., Girardier L., et al. Dietary supplementation with fish oil enhances invivo synthesis of tumor necrosis factor. Immunol Lett 1992, 34:13-17.
29. Damsgaard C.T., Lauritzen L., Holm P.M., Fruekilde M.B., Michaelsen K.F., Frokiaer H. Fish oil supplementation modulates immune function in healthy infants. JNutr 2007, 137:1031-1036.
30. Magee P., Pearson S., Allen J. The omega-3 fatty acid, eicosapentaenoic acid(EPA), prevents the damaging effects of tumor necrosis factor (TNF)-alphaduring murine skeletal muscle cell differentiation. Lipids Health Dis 2008, 7:1-11.
31. James M.J., Gibson R.A., Cleland L.G. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 2000, 71:343S-348S.
32. Martinez-Micaelo N., Gonzélez-Abuín N., Terra X., Ardèvol A., Penent M., Blay M. Omega-3 docosahexaenoic acid and procyanidins inhibit cyclooxygenase activity and attenuate NF-κB activation through a p105/p50 regulatory mechanism in macrophage inflammation. Biochem J 2012, 44:653-663.
33. Calder P.C. Fatty acids and inflammation: the cutting edge between food and pharma. Eur J Pharmacol 2011, 668:550-558.